Eisai and Biogen present promising lecanemab study results
Phase 3 research shows that Alzheimer’s disease treatment meets primary and secondary endpoints
30th November 2022
-
We've come a long way
People with HIV are living long and fulfilled lives but what is the future of HIV care?
-
Hearts and minds
Making mental health and well-being for all a priority
-
Listen without prejudice
The UK is making progress towards the zero HIV transmissions milestone
-
We can see clearly now
The ABPI has brought pharma transparency into the broader healthcare mix and HCP relationships are at its heart
News
View all
Otsuka receives vital Lupkynis MHRA authorisation
Therapy represents first oral calcineurin-inhibitor treatment for active lupus nephritis in adults
30th November 2022
Touchlight receives funding to develeop DNA vaccine platform
Bill & Melinda Gates Foundation grant will boost potential of nanoparticle-formulated doggybone DNA
29th November 2022
Immutep in clinical trail collaboration with Merck KGaA and Pfizer
Research will focus on eftilagimod alpha and avelumab for the treatment of urothelial cancer
29th November 2022
Almirall joins project to allow study participants to use trial data
Project involves 27 partners including patient associations, hospitals and universities
28th November 2022
Top trending
Bristol Myers Squibb immunotherapy-chemo combination gets NICE recommendation
Multi-drug precision medicine cancer trial begins
Recent Ozempic, Victoza data ‘promising’ for diabetic kidney disease
Storm doses first patient with solid tumour drug candidate
Medicines for Malaria Venture and Novartis move to phase 3 trial
PharmaTimes Magazine Archive
Magazine
View more from the latest edition
The human condition
Our AI guru looks at how decision-making can go to the next level with hyperautomation
Life cycle
How can pharma help the NHS to support older people better?
We can see clearly now
The ABPI has brought pharma transparency into the broader healthcare mix and HCP relationships are at its heart
Hearts and minds
Making mental health and well-being for all a priority
Cold comfort?
Decision intelligence can help to ease winter pressures on the NHS
Society’s ties
Delivering true value for people living with rare diseases comes from partnership and innovation
Listen without prejudice
The UK is making progress towards the zero HIV transmissions milestone
We've come a long way
People with HIV are living long and fulfilled lives but what is the future of HIV care?
Thought Leadership
View all
Empowering health innovation: Birmingham boosting lab capacity
Professor Gino Martini, CEO of the Precision Health Technologies Accelerator (PHTA Ltd), explains how Birmingham is providing the collaborative space to simultaneously drive innovation in pharma, and tackle health inequality.
Is the SmPC still relevant in the digital age?
Post-pandemic, we have been forced to rethink the way in which medicines information is disseminated and consumed.
Pharmaceutical Labelling Excellence with Epson ColorWorks Printers
For businesses operating in the pharmaceutical industry, patient safety is paramount and, when it comes to the labelling of products, devices or solutions used for medical purposes, clear, consistent and highly accurate labels are essential.
The difference a day makes
Kate Downey talks about changing career direction and embracing patient engagement
Webinars
View all
Diversity in Pharma: The Impact of COVID-19 on DE&I
Thursday, 23 June 2022 - 3:00 pm
COVID-19 has had a huge impact on how we all think and act. Our working environments may look very different now to the way they did pre-pandemic, and not all the changes have been negative.
Andrés López Castaño, Tricia Lucas-Clarke, Noor Shaker, Sandra Van de Cauter, Marsha N. Ganthier
FREE | REGISTER NOW
Patient Perspectives to Improve Retention with eConsent
Tuesday, 22 February 2022 - 4:00 pm
With Tufts reporting that the average number of patient dropouts for clinical trials remains near 30%, it is clear that there is still much to be done towards improving retention¹.
Andrew Mackinnon, Digital Trial Operations Lead, Medable
FREE | ATTEND
Focusing on Patient-centricity for the Future of Pharma
Wednesday, 21 July 2021 - 2:00 pm
In healthcare, the patient voice is arguably the most important. Services and care work best when a person’s needs are fully met and they feel heard, respected and valued.
Mark Doyle, co-founder of The Method and creator of A Life in a Day
FREE | ATTEND
Designing Pharma organisations for success
Wednesday, 28 September 2016 - 11:00 am
Across all industries, people are changing the ways they engage with products, services, and brands.
George Underwood
FREE - Listen again now - | VIEW NOW
